In IVD market oncology is one of the most sought-after segments by the manufacturers. Non-invasive cancer testing is expected to be a hot market in 2019. Qiagen, one of the global MNC, has been pioneering the use of liquid biopsy-based companion diagnostics as a less-invasive option to complement surgical biopsies for genomic profiling of cancers.
According to the latest report published by the company, the global gastrointestinal infection testing market is projected to account for over US$ 490.2 Mn, in terms of value, by 2026 end. The report further projects that the gastrointestinal infection testing market will grow at a CAGR of 5.1% through 2026.
According to the latest research report by IMARC Group, The global enteric disease testing market size reached US$ 4.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.1% during 2024-2032. More Info:- https://www.imarcgroup.com/enteric-disease-testing-market
Blood culture is a medical testing procedure to detect the presence for external objects, such as of microorganisms such as bacteria, fungi and other micro-organisms in the blood that might be an indication of a blood infection or bacteremia. The bacteria can begin on the skin, lungs, urine or even gastrointestinal tract which are prevalent causes of blood infection. If left undetected the infection can cause serious and fatal condition called sepsis.
According to the latest research report by IMARC Group, The global enteric disease testing market size reached US$ 4.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.0 Billion by 2028, exhibiting a growth rate (CAGR) of 3.4% during 2023-2028. More Info:- https://www.imarcgroup.com/enteric-disease-testing-market
The global enteric disease testing market size reached US$ 3.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2027, exhibiting a growth rate (CAGR) of 3.57% during 2022-2027. More info:- https://www.imarcgroup.com/enteric-disease-testing-market
Global Market Insights Inc. add New Report Global Microbiology Testing Market to its research database. The report focuses on global major leading players with information such as company profiles, Growth, product segment, technology segment, end user segment and region.
Looking forward, the enteric Disease testing market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/enteric-disease-testing-market
The development of technologically advanced products is positively impacting the hospital-acquired infection (HAI) diagnostics domain. Advancements in technology have revolutionized the HAI diagnostics domain by enabling the development of products that offer reliable results in less time. For instance, in 2017, Roche Diagnostics launched the cobas Liat PCR system with four assays with the ability to conduct a real-time PCR nucleic acid test for Clostridium difficile detection in 20 minutes.
Global Food Safety Testing Market is expected to reach USD 22,327.02 million by 2025 from USD 12,760.00 million in 2017, at a CAGR of 7.5% in the forecast period 2018 to 2025.
Blood culture is a test to check for external objects, such as yeast, bacteria and other micro-organisms in your body may be an indication of a blood infection, or a disease recognized as bacteremia. A favorable blood culture implies your blood contains bacteria. This sort of infection includes the blood that circulates throughout your flesh. Bacteria that begin on your skin or in your urine, lungs, or gastrointestinal tract are prevalent causes of blood infection.
The global digital PCR market is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022-2032.
Gastric cancer testing market, size, share, market intelligence, company profiles, market trends, strategy, analysis, forecast 2017-2022 STOMACH CANCER MARKET INSIGHTS The Stomach cancer market is expected to grow at a modest CAGR of 5.8% during 2017-2022. Growing elderly population, technological advancement and rising incidence and prevalence rate of gastric cancer are boosting the stomach cancer market across the globe. Gastric cancer leads to uncontrolled progress of malignant cells that originate in stomach tissue.
The report also profiles several other prominent players competing in the mucus clearance devices market, which include Allergan plc, Koninklijke Philips N.V., Respiratory Technologies, Inc., Smiths Medical
Clostridium Diagnostics Market size is estimated to reach $1.9 billion by 2027, growing at a CAGR of 7.3% during the forecast period 2022-2027. Clostridium is a gram-positive bacterium that can be found in a variety of forms. Disease-causing form of Clostridium bacteria which causes Clostridium difficile infection (CDI), a gastrointestinal ailment, frequently considered synonymous with antibiotic-associated diarrhea (AAD), is Clostridioides difficile. Clostridium perfringens, Clostridium botulinum, Clostridium tetani and Clostridium sordellii cause gas gangrene, muscle necrosis, botulism, tetanus, pneumonia, endocarditis, arthritis and peritonitis.
Edward Food Research and Analysis Centre (EFRAC) is a Food Testing, Drug, Testing, Water Testing, Proficiency testing Laboratory situated in Kolkata, India.
The probiotic Ingredients in Human Nutrition Market is anticipated to grow at a CAGR of around 8.4 % during the forecast period, i.e., 2022-27. The mounting trend of probiotic ingredients in dietary supplements to prevent gastrointestinal issues & cardiovascular diseases drives the market. Read More: https://www.marknteladvisors.com/query/request-sample/global-probiotics-ingredients-in-human-nutrition-market.html
It highlights the competitive outlook of major global players that includes the business strategies, product portfolio, revenue distribution, financial analysis, R&D activities and investments. The in-depth analysis of facility management market report will help the clients to assess their business strategies as per the competitive environment in the market space.
Echovirus Diagnostics Market size is estimated to reach $231.5 million by 2027, growing at a CAGR of 3.2% during the forecast period 2022-2027. The echovirus is one of the numerous kinds of viruses that reside in the digestive system, also termed the gastrointestinal (GI) tract. The name “echovirus” is derived from the enteric cytopathic human orphan (ECHO) virus. Echoviruses are associated with a class of viruses termed enteroviruses.
JNJ. Live by the Credo. Broad base in human health care ... JNJ 10 yr Snapshot. Growth & Innovation. J&J has a structure 3 step formula for the future : ...
Increasing investment in R&D in molecular diagnostics, new product development, and rising prevalence of targeted diseases are some key factors driving market revenue growth.
The global Endoscopic Retrograde Cholangiopancreatography (ERCP) market size was USD 1.40 Billion in 2022 and is expected to register a rapid revenue CAGR of 4.3% during the forecast period, according to latest analysis by Emergen Research. Surge in procurement of endoscopy devices in healthcare facilities and rapid increase in popularity of minimally invasive surgeries are key factors driving market revenue growth.
A recent report published by The Business Research Company on Pharmaceutical Drugs Market provides in-depth analysis of segments and sub-segments in the global as well as regional. http://bit.ly/2m7j1Wy
In vitro diagnostics (IVD) is the technique in which medical devices and reagents are used to examine specimens such as blood, urine, stool, tissues and other body fluids, which are derived from the human body to detect diseases, conditions and infections. Check complete report @ http://www.marketintelreports.com/report/allied0099/world-in-vitro-diagnostics--market-opportunities-and-forecasts-2015--2022
The global pharmaceutical drugs market was valued around $935 billion in 2017. North America was the largest region in the pharmaceutical drugs market in 2017, accounting for around 37% of the total market. Read Report https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report-2018
0.3% to 7% of all hospital admissions. annual dollar costs in the billions ... 2 days. Classification. Severity of reaction: Mild. bothersome but requires no ...
Industry Experts unveiled the new market research report on Influenza. The new global report ‘Global Influenza Market – Vaccines and Therapeutics’ reveals that the market for seasonal influenza vaccines is estimated at 543 million doses valued at US$4.9 billion in 2016 and projected to touch US$714 million doses equated to US$7.9 billion by 2022. In terms of market value, North America is estimated the largest market with US$2.1 billion in 2016 while Europe is projected to be the fastest growing market for Influenza vaccines during the analysis period 2016-2022 with a CAGR of 11.7%. Hyderabad, India based Industry Experts is a multi industry focused business information provider. For more details, please visit http://industry-experts.com/verticals/healthcare-and-pharma/global-influenza-market-vaccines-and-therapeutics
The molecular point of care diagnostics market is estimated to grow at a CAGR of 14.05% and expected to reach $7398.82 million by 2028. Get a Free Sample Report.
Increasing investment in R&D in molecular diagnostics, new product development, and rising prevalence of targeted diseases are some key factors driving market revenue growth.
the 21st Century William A. Rutala, Ph.D., M.P.H. UNC Health Care and UNC School of Medicine, Chapel Hill, NC Disclosure This educational activity is brought to you ...
Vietnam medical devices market report includes total spending by public and private hospitals, clinical laboratories, polyclinics and medical research and education institutes on diagnostic imaging equipments, medical consumables, orthopedics and prosthetic devices, dental products, patient aid devices and several other medical equipments. For more information on the research report visit https://www.kenresearch.com/healthcare/medical-devices/vietnam-medical-devices-market/143604-91.html
Stay up-to-date with latest Insights of In Vitro Diagnostics market research offered by Allied Market Research. Check how key trends and emerging drivers are shaping this industry growth.
According to #TechSci Research report, increasing prevalence of air borne diseases and the rising demand for healthcare services is expected to drive the demand for
Global gastric cancer market is conspicuous by poor prognosis, because of the indolent nature of the disease. For more mail: vikas@konceptanalytics.com
Design and Analysis of Phase I Clinical Trials in Cancer Therapy Merrill J. Egorin, M.D. University of Pittsburgh Cancer Institute Modified from previous talks given ...
Food Supply Protection in an Age of Biocrimes, Terrorism, and Emerging Infections ... No meat or dairy, no aquariums, no circuses, no hunting or fishing, no fur or ...
Investigation of Suspected Cases of Human Infection with Avian Influenza A (H5N1) Virus * * Basic aspects of the investigation that we should evaluate at each phase ...
The Global Lateral Flow Assay Market was valued at USD9.3 billion in 2022 and is projected to grow at a CAGR of around 3.4% during the forecast period, i.e., 2023-28.
UAE is an import driven market in context to medical devices. The imports of medical devices accounted for a lion share of ~% from the total revenue market in 2015. The market is observed to grow at a rapid pace of ~% by value from 2010 to 2015 owing to the expanding healthcare infrastructure in the country; both the government and private healthcare sector is investing heavily to provide country satisfactory healthcare solutions to the residents, expats, and medical tourists.
The industry analysis specialist, has released its new report, Graves Disease Therapeutics - Pipeline Assessment and Market Forecast to 2019. The report is an essential source of information and analysis on the global Graves Disease Therapeutics market. The report identifies the key trends shaping and driving the global Graves Disease Therapeutics market. For more information : http://bit.ly/1xOeumU
ACELEX capsule 2mg - Tissue Selective COX-2 inhibitor CrystalGenomics Acelex NC Jan2016. Acelex® (polmacoxib) is a non-steroidal anti-inflammatory drug (NSAID), specifically a COX-2 inhibitor, for the treatment of symptoms associated with arthritis. Suffering from joints pain which might have been due to age or other reason. Acelex capsule 2 mg is one of new drug in the market for joints pain relief.
The red top tube either contains nothing or something to activate the formation of the clot. ... The Red Top Tube Goes to the Chemistry Lab. The serum can now ...
Why have 'Diet Plans' typically failed to make much difference in most IBS or Migraine patients? ... per month, 85% of patients becoming headache-free. ...
Bad Digestion By Dr. Joel Doughten ABDOMINAL PAIN PROGNOSIS Dyspepsia is typically a relapsing condition. In studies, 60 to 90 percent of people continue to have ...
The Pharmaceutical Industry in Perspective. Challenges. Opportunities ... Largest outsourcing agreement of it's kind in the pharmaceutical industry. Drivers: ...